Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by LannyMcdonaldon May 07, 2018 5:05pm
120 Views
Post# 27993855

Ministry of Health and Long-term Care

Ministry of Health and Long-term Care

email to Ministry of Health and Long-Term Care/dr/HLTC2966MC-18-3472

April 27, 2018 at 1240 pm


Thank you for your online message to the Ministry of Health and Long-Term Care (ministry) regarding the screening for diabetic retinopathy. The ministry appreciates this opportunity to respond.
 
The physician service of using an artificial intelligence-based screening model for diabetic retinopathy is not listed in the Schedule and is therefore not an insured physician service.
 
You may be interested to know that the ministry has a process in place to review advances in technology, clinical evidence, and expert advice to determine whether new health technologies and services should be added to the Schedule of Benefits for Physician Services (the Schedule). Health Quality Ontario (HQO) and the Ontario Health Technology Assessment Committee (OHTAC) conduct reviews of new technologies and services and provide advice and recommendations to the ministry. Through this process, the ministry is assured that new services are generally recognized by appropriate specialists as being medically necessary and that appropriate definitions, conditions, clinical eligibility criteria and fees are determined.
 
To date, OHTAC has not reviewed the use of Diagnos’ technology for screening diabetic patients.
 
The public can request that OHTAC conduct a review of a specific health technology, provided that it meets the application criteria. You can find more information online at https://www.hqontario.ca/ .
 
I trust this information is helpful. Thank you again for writing.

Sincerely,
D. Ramanayake
Correspondence Services
Ministry of Health and Long-Term Care


If you go to the above link for hqontarrio.ca and scroll to the contact us, you can send  a email with regards to our AI technology. I will send one but it would be nice if everyone sent an email. This is new technology and they are willing to listen. 

Let your voice be heard ! 
 

Bullboard Posts